Opinion

Video

The Contemporary Treatment Landscape of mCRPC

Author(s):

Evan Yu, MD ,Jack R. Andrews, MD

Panelists discuss how the evolving treatment landscape for metastatic castration-resistant prostate cancer (mCRPC) encompasses multiple therapeutic options including novel hormonal agents, chemotherapy, and targeted therapies while highlighting persistent challenges in treatment sequencing, drug resistance, and the need for improved biomarker-driven approaches to optimize patient outcomes.

Video content above is prompted by the following:

  • Can you briefly discuss the contemporary treatment landscape of mCRPC?
  • What are the unmet needs for the treatment of mCRPC? Eg, access to agents.
  • Treatment optimization to further delay disease progression and improve overall survival
Related Videos
1 expert is featured in this series.
1 expert is featured in this series.
3 experts are featured in this series.
1 expert is featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
1 expert is featured in this series.
Related Content
Survey: New NMIBC treatments face slow uptake
June 2nd 2025

Survey: New NMIBC treatments face slow uptake

Benjamin P. Saylor
Results of an exclusive Urology Times survey point to urologists preferring intravesical chemotherapy for treating BCG-unresponsive NMIBC.
Pearls & Perspectives: Understanding and Improving Pelvic Health, with Diane Newman, DNP
June 2nd 2025

Pearls & Perspectives: Understanding and Improving Pelvic Health, with Diane Newman, DNP

Amy M. Pearlman, MD
Du Geon Moon, MD, PhD | Credit: Korea University College of Medicine
April 27th 2025

Sildenafil/Clomipramine Combo Boosts Outcomes in Premature Ejaculation

Patrick Campbell
A phase 3 trial reveals a combination therapy for premature ejaculation significantly enhances treatment outcomes.
Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD
May 17th 2025

Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD

Amy M. Pearlman, MD Alex Tatem, MD
Explore the latest insights on testosterone therapy, its benefits, and practical applications from leading urologists in men's health.
Nathan Lawrentschuk, MBBS, PhD | Credit: Epworth Healthcare
April 26th 2025

ADAM, a long-term, injectable male birth control, shows promise at AUA 2025

Patrick Campbell
A groundbreaking male contraceptive shows promising safety results, offering a reversible option for couples seeking effective birth control.
Stacy Loeb, MD, MSc, PhD | Credit: NYU Langone Health
April 26th 2025

TikTok, social media does more harm than good for prostate cancer education

Patrick Campbell
Social media spreads significant misinformation about prostate cancer. Experts urge clinicians to provide trusted information sources.
© 2025 MJH Life Sciences

All rights reserved.